CHICAGO (December 14, 2023)—Perkins Coie is pleased to have represented TRACT Therapeutics, a clinical stage biotechnology company, in its strategic collaboration deal to advance cellular therapy with Taiwan Bio, a one-stop, total solution cell therapy contract development and manufacturing organization. For more information, please see TRACT Therapeutics’ press release here. 

The new strategic collaboration between Taiwan Bio and TRACT Therapeutics will work to advance cellular therapy to revolutionize the prevention of allograft rejection in solid organ transplants. The partners will launch a multi-center Phase 2 clinical trial investigating the reduction of immunosuppressant drugs in living donor kidney transplant recipients in both the United States and Taiwan. 

The Perkins Coie team that advised TRACT Therapeutics included partners Steven Ducommun and Mark Wicker, and associate Alina Litoshyk. 

Perkins Coie is a leading international law firm that is known for providing high-value, strategic solutions and extraordinary client service on matters vital to our clients’ success. With more than 1,200 lawyers in offices across the United States and Asia, we provide a full array of corporate, commercial litigation, intellectual property, and regulatory legal advice to a broad range of clients, including many of the world’s most innovative companies and industry leaders as well as public and not-for-profit organizations.

Media Inquiries: Please email Justin Cole, Head of Media Relations.